Raptor Pharmaceutical (RPTP)
Add to Watchlists Create an AlertRPTP Key Stats
| Income Statement | |
| Revenue TTM | 0.00 |
| Revenue Quarterly YoY Growth | |
| EPS Diluted TTM | -0.8153 |
| EPS Diluted Quarterly YoY Growth | |
| Net Income TTM | -40.61M |
| Profitability | |
| Gross Profit Margin Quarterly | |
| Profit Margin Quarterly | |
| Dividend | |
| Dividend Yield | 0.00% |
| Payout Ratio TTM Pro | Go Pro |
| Current Valuation | |
| Market Cap | 349.93M |
| Enterprise Value | 306.96M |
| PE Ratio TTM | |
| PE 10 Pro | Go Pro |
| PEG Ratio | |
| Price / Book Value | 14.96 |
| Other | |
| Beta Pro | Go Pro |
| Debt to Equity Ratio | 0.00 |
| Free Cash Flow | -10.21M |
| Return on Equity | -144.6% |
RPTP News
- RAPTOR PHARMACEUTICAL CORP Files SEC form 8-K, Results of Operations and Financi... May 9
- Raptor Pharmaceutical Reports First Quarter Calendar Year 2013 Financial Results GlobeNewswire May 8
- RAPTOR PHARMACEUTICAL CORP Files SEC form 10-Q, Quarterly Report May 8
- 3 Healthcare Stock Stories For Tuesday Investment Wellness May 7
- Raptor licenses IP for Rett Syndrome from French Research Institute May 7
- Raptor Pharmaceutical Licenses Intellectual Property for Rett Syndrome Benzinga May 7
- Raptor Pharmaceutical Licenses Intellectual Property for Rett Syndrome From Fren... May 7
- This Week in Biotech May 4
- Two Different Outlooks for Two Tuesday Performers May 2
- Wedbush Downgrades Raptor Pharmaceuticals (RPTP) to Neutral Street Insider May 2
RPTP Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Raptor Pharmaceutical is up 22.70% over the last year vs S&P 500 Total Return up 28.33%, AstraZeneca up 32.92%, and GW Pharmaceuticals down 0.23%.
RPTP Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Cash Flow Statement View Statement
You may also be interested in these RPTP related companies
Pro Ratings for RPTP
Pro Report PDF for RPTP
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.
Download RPTP Pro Report PDF
Pro Strategies Featuring RPTP
Did Raptor Pharmaceutical make it into our Pro Portfolio Strategies?
RPTP Profile
Sector: Healthcare
Industry: Drug Manufacturers - Major
Other RPTP Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership MSN Money
- SEC Filings SEC
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| RPTP | 6.54 | +0.14 | +2.19% | 349.93M |
